Design, Conduct and Interpretation of Clinical Trials in Movement Disorders
October 29-31, 2013 ♦ Toulouse, France
Jointly organized by the French Clinical Research Infrastructure Network (F-CRIN) and MDS-ES, this was a 3-day teaching course. It comprised an optional first day on the semiology of Parkinson’s disease and Huntington’s disease and 2 days focused on the development of clinical trials in these pathologies mixing plenary sessions and workshops. The training course was held at the Toulouse Medical Faculty (37 Allée Jules Guesde - Toulouse). Its specific goal was to improve the efficiency and development of clinical trials in movement disorders by:
- Introducing pharmaceutical industry professionals to the phenomenology and management in Parkinson’s disease and Huntington’s disease
- Introducing investigators to the fundamentals of effective clinical trial design. The course will cover key topics in methodology, study design, and results analyses.
- Developing a clinical research protocol
This course was targeted toward pharmaceutical industry professionals and academic researchers who want to acquire skills in the methodology of clinical trials in movement disorder disease.
For more information contact: